Healthcare specialist Nathalie Flury is set to depart Swiss & Global Asset Management later this month, the Swiss group has announced.
Flury joined the Zurich-based company in 2008 from asset manager Clariden Leu and had overseen the Julius Baer EF Health Innovation.
The Health Innovation fund, which she ran since launch in 2008, will now be overseen by her co-manager Christophe Eggmann.
Eggmann assumed the role as sole lead on the Luxembourg-domiciled, which invests across the healthcare sector with a particular focus on biotech, on August 1.In a statement to investors, Swiss & Global Asset Management said: ‘Nathalie Flury, who worked alongside Christophe, will be leaving the company in mid-September to pursue a new opportunity. The fund’s objective and successful investment approach will, however, remain unchanged.’
In addition, Swiss & Global Asset Management said it would be looking to add a new portfolio manager to its healthcare team following Flury’s exit.
The $105 million Julius Baer EF Health Innovation fund returned 25.1% in US dollar terms over the three years to the end of August 2014. Its benchmark, the MSCI World /Health TR USD, rose 15.8% over the same period.